InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Shannon John Patrick Jr, Dirigeant. Director active across 2 companies, notably Xeris Pharmaceuticals INC. In total, 8 filings have been recorded. Total volume traded: €145k. The latest transaction was disclosed on 3 January 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations8 total
0250,000 shares0
Common Stock
SEC:0001867096-22-000008:0·
0250,000 shares0
Common Stock
SEC:0001867096-22-000008·
€72,69840,000 shares@ €1.81740.0056% mcap100.0% of flow
Common Stock
SEC:0001867096-21-000077·
Ideal exit: 8 Aug 2022 (T+270)
€72,69840,000 shares@ €1.81740.0056% mcap50.0% of flow
Common Stock
SEC:0001867096-21-000077:0·
Ideal exit: 8 Aug 2022 (T+270)
70,496 shares
Common Stock
SEC:0000899243-21-039333·
70,496 shares
Common Stock
SEC:0000899243-21-039242·
70,496 shares
Common Stock
SEC:0000899243-21-039333:0·
70,496 shares
Common Stock
SEC:0000899243-21-039242:0·
8 of 8 declarations
About Shannon John Patrick Jr
John Patrick Jr. Shannon is an executive at Xeris Biopharma Holdings, Inc. and XERIS Pharmaceuticals Inc. Although his specific role is not detailed, he is involved in managing the company's operations. Xeris specializes in developing biopharmaceutical treatments. John contributes to the strategic direction and execution of projects within the organization.
